Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Eddy

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer|March 15, 1980
Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: methods of documenting tumor response and progressionD C Ihde, P A Bunn, M H Cohen, et al.
The American Journal of Medicine|March 1, 1985
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survivalD C Ihde, M J Matthews, R W Makuch, et al.
Cancer Treatment Reports|December 1, 1984
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsivenessG Morstyn, G P Schechter, D C Ihde, et al.
Annals of Internal Medicine|September 1, 1988
Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groupsE A Sausville, J L Eddy, R W Makuch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostateE J Seifter, P A Bunn, M H Cohen, et al.
Investigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-upC F Winkler, E A Sausville, D C Ihde, et al.
Cancer Treatment Reports|April 1, 1979
Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomasP A Bunn, A B Fischmann, G P Schechter, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer|March 15, 1980
Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: methods of documenting tumor response and progressionD C Ihde, P A Bunn, M H Cohen, et al.
The American Journal of Medicine|March 1, 1985
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survivalD C Ihde, M J Matthews, R W Makuch, et al.
Cancer Treatment Reports|December 1, 1984
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsivenessG Morstyn, G P Schechter, D C Ihde, et al.
Annals of Internal Medicine|September 1, 1988
Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groupsE A Sausville, J L Eddy, R W Makuch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostateE J Seifter, P A Bunn, M H Cohen, et al.
Investigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-upC F Winkler, E A Sausville, D C Ihde, et al.
Cancer Treatment Reports|April 1, 1979
Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomasP A Bunn, A B Fischmann, G P Schechter, et al.
Pageof 2